SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

CNS Pharmaceuticals, Inc. (CNSP) News

Follow CNS Pharmaceuticals, Inc. (CNSP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol CNSP Asset equity Sector Markets 90 days 5 Last 4.39 Updated Sep 01, 2026, 01:06 PM UTC Open live news feed Open CNSP chart & news
L CNSP - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth CNSP - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth EQUITY | Sep 01, 2026, 01:06 PM UTC L CNS Pharmaceuticals COO Dylan Wenke joins investor segment discussion CNS Pharmaceuticals said Chief Business Officer Dylan Wenke participated in a virtual investor "What This Means" segment on TradingView News. EQUITY | Sep 01, 2026, 01:01 PM UTC L JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs EQUITY | Aug 27, 2026, 01:01 PM UTC L CNS Pharmaceuticals to participate in Virtual Investor conference CNS Pharmaceuticals will participate in the Virtual Investor "Why Now" on-demand conference. EQUITY | Aug 27, 2026, 01:01 PM UTC L CNSP - CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference CNSP - CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference EQUITY | Aug 27, 2026, 01:01 PM UTC L CNSP Reports Second Quarter 2026 Results CNS Pharmaceuticals reports second quarter 2026 results with a strengthened balance sheet EARNINGS | Aug 12, 2026, 12:00 PM UTC L 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Can Fite Biopharma (AMEX: CANF ) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million. Atlantic International (NASDAQ: ATLN ) shares rose 17 EQUITY | Jul 01, 2026, 12:05 PM UTC